DRONABINOL | A078292 | RHODES PHARMACEUTICALS
No patent or exclusivity listings for this strength.
RHODES acquired dronabinol NDA 078292 from SVC Pharma, assuming applicant responsibilities for this cannabinoid product.
Old: SVC PHARMA
New: RHODES
RHODES PHARMACEUTICALS acquired the NDA for dronabinol (NDA 078292), replacing SVC PHARMA LP as the listed applicant.
Old: SVC PHARMA LP
New: RHODES PHARMACEUTICALS
Rhodes Pharmaceuticals succeeded SVC Pharma LP as the applicant for Dronabinol NDA 078292.
Old: SVC PHARMA LP
New: RHODES PHARMACEUTICALS
Rhodes acquired rights to Dronabinol (NDA 078292, Supplement 003) from SVC Pharma, replacing the previous applicant of record.
Old: SVC PHARMA
New: RHODES
Rhodes Pharma acquired the NDA for dronabinol (NDA 078292), replacing SVC Pharma as the listed applicant.
Old: SVC PHARMA
New: RHODES
Rhodes Pharmaceuticals assumed applicant responsibility for dronabinol (NDA 078292) from SVC Pharma LP.
Old: SVC PHARMA LP
New: RHODES PHARMACEUTICALS